Keyl, Cornelius http://orcid.org/0000-0002-1818-4819
Bashota, Albina
Beyersdorf, Friedhelm
Trenk, Dietmar
Funding for this research was provided by:
Albert-Ludwigs-Universität Freiburg im Breisgau
Article History
Accepted: 24 June 2021
First Online: 7 July 2021
Declarations
:
: D. Trenk received consulting fees or advisory board fees and lecture fees paid by Amgen, AstraZeneca, Bayer, Boehringer Ingelheim KG, Bristol Myers Squibb, Daiichi Sankyo, Ferrer, Eli Lilly, and Pfizer. C. Keyl, F. Beyersdorf, and A. Bashota: no conflicts of interest to declare.
: The study protocol was approved by the local ethics committee who waived the need for obtaining informed consent of patients for this retrospective analysis (application ID 110/19, approved on July 2, 2019).